Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Neural Analytics, Inc. to Present at Needham & Company’s 17th Annual Healthcare Conference

Neural Analytics,Inc.
Posted on: 22 Mar 18

Neural Analytics, Inc., a medical device company developing and commercializing technologies to measure, diagnose and track brain health, today announced that Anjan Chatterji, Executive Vice President of Corporate Development and Strategy, and Henry Hewes, Vice President of Sales and Global Marketing, will present at the Needham & Company's 17th Annual Healthcare Conference on Wednesday, March 28, 2018 at 9 a.m. EDT, at the Westin Grand Central Hotel in New York. They will discuss the commercial and capital goals of the company since its recent closing of a $15M Series B financing.

About Neural Analytics, Inc.

Neural Analytics, Inc. was founded in 2013 to create products and services to measure, diagnose and track brain health. The company’s current focus is on acute ischemic stroke, traumatic brain injury and dementia. They combine leading data science with cutting edge hardware to allow first responders and clinicians to accurately assess and monitor brain health issues. Their devices are designed to be portable, autonomous, reliable and produce precise and objective physiological measurements for medical responder monitoring of neural disorders.

View source version on

Business Wire

Last updated on: 22/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.